SCHEMBL24144161

SCHEMBL24144161

CCC(=O)N[C@H](C(=O)N(CC)CC)C(C)(C)SC(=O)CCC(=O)SC(C)(C)[C@H](OC(=O)CC)C(=O)N(CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18737710 0.88 CYP2C9 (0.32) —
SCHEMBL18735153 0.81 — —
SCHEMBL18735143 0.80 LMNA (0.31) —
SCHEMBL18735195 0.79 GAA (0.34) —
SCHEMBL18735236 0.77 — —
SCHEMBL18734937 0.76 — —
SCHEMBL18734964 0.74 — —
SCHEMBL18734951 0.74 — —
SCHEMBL18734970 0.72 MGAM (0.33) —
SCHEMBL17169993 0.72 CA1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210401792-A1 NOVEL CELL-PERMEABLE SUCCINATE COMPOUNDS Abliva Ab (SE) 2021-12-30 — — US disclosed
Send feedback